Skip to main content

Table 2 KEGG pathways enriched in secondary viral interactors

From: Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses

Pathway Name Pathway ID Observed Random Odds Ratio FDR FDR-Corr
Apoptosis hsa04210 6 1.82 3.31 1.3E-04 1.9E-02
Cell cycle hsa04110 10 2.87 3.48 3.6E-04 4.8E-02
Chronic myeloid leukemia hsa05220 8 1.59 5.03 2.1E-05 3.2E-03
Colorectal cancer hsa05210 7 2.13 3.28 9.3E-05 1.4E-02
ErbB signaling pathway hsa04012 7 1.67 4.19 6.3E-05 9.5E-03
Glioma hsa05214 7 0.76 9.26 6.2E-05 9.3E-03
Huntington's disease hsa05040 6 0.34 17.41 < 2.5E-06 < 3.8E-04
Insulin signaling pathway hsa04910 10 2.06 4.86 1.2E-04 1.8E-02
Melanoma hsa05218 4 0.64 6.27 1.4E-04 2.0E-02
Notch signaling pathway hsa04330 4 1.82 2.20 < 2.5E-06 < 3.8E-04
Olfactory transduction hsa04740 4 0.16 25.66 < 2.5E-06 < 3.8E-04
Prostate cancer hsa05215 5 1.04 4.79 2.9E-04 4.3E-02
Ubiquitin mediated proteolysis hsa04120 10 3.02 3.31 2.0E-04 2.9E-02